Lupin Limited — Updates, 07-03-2026: General Updates
07-03-2026 | 05:55 pm
07-03-2026 | 05:55 pm
Lupin's Ankleshwar manufacturing facility concluded a US FDA inspection with a Form-483 citing two observations. The company plans to address these promptly, reiterating its commitment to CGMP standards.
No comments yet. Be the first to comment!
